Investigating the impact of PFAS on kidney disease in young people with type 2 diabetes
PFAS and Diabetic Kidney Disease in Young Onset Type 2 Diabetes: Emerging Risk Factors and Underlying Mechanisms
This study is looking at how certain chemicals called PFAS might affect kidney health in young people with type 2 diabetes, helping to find out who might be at risk for kidney problems and how these chemicals could be involved.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project ID | NIH-11075249 on NIH RePORTER |
What this research studies
This research focuses on understanding how exposure to PFAS, a group of artificial chemicals, may contribute to diabetic kidney disease (DKD) in young individuals with type 2 diabetes. By analyzing existing health data and biological samples from a long-term study, researchers aim to identify youth at risk for DKD and explore the underlying mechanisms linking PFAS exposure to kidney function impairment. The study will measure levels of various PFAS and their potential effects on kidney health over time.
Who could benefit from this research
Good fit: Ideal candidates for this research are young individuals aged 12 to 20 who have been diagnosed with type 2 diabetes.
Not a fit: Patients who do not have type 2 diabetes or are outside the age range of 12 to 20 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better identification and management of kidney disease in young people with type 2 diabetes, ultimately improving their health outcomes.
How similar studies have performed: While the association between PFAS exposure and kidney disease is emerging, this specific approach to studying its effects in youth with type 2 diabetes is novel and has not been extensively tested.
Where this research is happening
Los Angeles, UNITED STATES
- University of Southern California — Los Angeles, United States (Active)
Researchers
- Principal investigator: Goodrich, Jesse Allen — University of Southern California
- Study coordinator: Goodrich, Jesse Allen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.